Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis

Scand J Infect Dis. 1994;26(2):179-87. doi: 10.3109/00365549409011782.

Abstract

Patients seeking medical attention for respiratory infections were investigated with serology and culture for Chlamydia pneumoniae to investigate the prevalence of C. pneumoniae in a specific geographical area and its association with respiratory disease. Evidence for C. pneumoniae infection was found in approximately 25% of cases. 71% of patients with C. pneumoniae had symptoms from the lower respiratory tract as compared to 29% of the others. We conclude that C. pneumoniae can be a major cause of acute bronchitis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Bacterial / blood
  • Bronchitis / drug therapy
  • Bronchitis / epidemiology*
  • Bronchitis / microbiology
  • Child
  • Chlamydia Infections / drug therapy
  • Chlamydia Infections / epidemiology*
  • Chlamydophila pneumoniae* / immunology
  • Chlamydophila pneumoniae* / isolation & purification
  • Female
  • Humans
  • Immunoglobulin A / blood
  • Immunoglobulin G / blood
  • Male
  • Middle Aged
  • Prevalence

Substances

  • Anti-Bacterial Agents
  • Antibodies, Bacterial
  • Immunoglobulin A
  • Immunoglobulin G